
November 3, 2017 - By Nellie Frank
BioTime, Inc. is a clinical-stage biotechnology firm focused on developing and commercializing products addressing degenerative diseases. The company has market cap of $290.38 million. The Company’s clinical programs are based on two platform technologies: pluripotent stem cells and cell/drug delivery platform technologies. It has a 3.98 P/E ratio. The foundation of its cell delivery platform is its HyStem cell and drug delivery matrix technology.Ycg Llc decreased Unilever N V (NYSE:UN) stake by 42.4% reported in 2017Q3 SEC filing. Ycg Llc sold 206,186 shares as Unilever N V (NYSE:UN)’s stock rose 12.65%. The Ycg Llc holds 280,091 shares with $16.55 million value, down from 486,277 last quarter. Unilever N V now has $167.92 billion valuation. The stock increased 0.21% or $0.12 during the last trading session, reaching $57.27. About 742,860 shares traded. Unilever NV (ADR) (NYSE:UN) has risen 26.55% since November 3, 2016 and is uptrending. It has outperformed by 9.85% the S&P500.Among 9 analysts covering Unilever NV (NYSE:UN), 5 have Buy rating, 1 Sell and 3 Hold. Therefore 56% are positive. Unilever NV had 11 analyst reports since September 25, 2015 according to SRatingsIntel. Jefferies upgraded the stock to “Buy” rating in Tuesday, December 13 report. RBC Capital Markets downgraded the shares of UN in report on Friday, July 22 to “Sector Perform” rating. Citigroup upgraded the stock to “Buy” rating in Wednesday, August 31 report. JP Morgan upgraded the shares of UN in report on Tuesday, January 12 to “Overweight” rating. Berenberg upgraded the stock to “Buy” rating in Friday, September 25 report. As per Friday, March 24, the company rating was upgraded by Barclays Capital. RBC Capital Markets downgraded Unilever NV (ADR) (NYSE:UN) on Thursday, August 10 to “Underperform” rating. The firm earned “Outperform” rating on Monday, August 22 by Bernstein. The firm has “Neutral” rating by Credit Suisse given on Tuesday, December 8. The firm has “Neutral” rating by JP Morgan given on Wednesday, December 7.Unilever N.V. is a fast-moving consumer goods company. The company has market cap of $167.92 billion. The Company’s divisions include Personal Care, which primarily includes sales of skin care and hair care products, deodorants and oral care products; Foods, which primarily includes sales of soups, bouillons, sauces, snacks, mayonnaise, salad dressings, margarines and spreads; Home Care, which primarily includes sales of home care products, such as powders, liquids and capsules, soap bars and a range of cleaning products, and Refreshment, which primarily includes sales of ice cream and tea beverages. It has a 24.22 P/E ratio. The Company’s geographical divisions include Asia/AMET/RUB, The Americas and Europe. Ycg Llc is a Texas-based institutional investor with more than $279.00 million AUM in April, 2014. Taken from Ycg latest Adv, the fund reported to have 5 full and part-time employees. Among which 5 performing investment advisory and research functions. The institutional investor had between 26-100 clients.Broadwood Capital Inc holds 15.71% of its portfolio in BioTime, Inc. for 27.12 million shares. Manatuck Hill Partners Llc owns 620,350 shares or 0.98% of their US portfolio. Moreover, Prescott General Partners Llc has 0.31% invested in the company for 1.85 million shares. The New York-based Family Management Corp has invested 0.3% in the stock. Tfs Capital Llc, a Pennsylvania-based fund reported 182,390 shares.Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.


var data = "63557954";
document.write('<ins class="adsbygoogle" style="background-color:transparent; display:inline-block;width:300px;height:600px;" data-ad-client="ca-pub-16900'+data+'675" data-ad-slot="8925061741"></ins>')

(adsbygoogle = window.adsbygoogle || []).push({});
(adsbygoogle = window.adsbygoogle || []).push({});